Established in 2018, Odin Pharmaceuticals is a generic drug development company focused on difficult-to-develop and manufacture drug products.  While the company is new, it’s management team has decades of experience and accomplishments:

• Track record with successful commercial launch of over 300 drug products with revenues of $800 million
  • Generic drug savings to customers and patients exceeding $3 billion in discounts
• Exceptional compliance record with the FDA and many other regulatory agencies (DEA, EPA, etc.)
  • No FDA warning letters
  • Successful remediation of previous management’s warnings letters and consent decrees
• Creation of 500 US scientists jobs and employment of 400 ex-US pharmaceutical jobs
• Founding, development, and sale of multiple pharmaceutical firms totaling $1.1 billion

The privately-held company has its headquarters and development facility in Somerset, New Jersey.